# GE Healthcare invests RMB 380 million to expand diagnostic pharmaceutical operations in Shanghai

GE Healthcare signed a letter of intent with the Pudong New District government to invest an additional RMB 380 million in its Shanghai diagnostic drug production base, covering new product introduction, new production lines, green upgrades, and digital transformation.

- Type: Investment
- Announced: 2024-05-15
- Where: Zhangjiang, Pudong, Shanghai, China
- Value: $52.7M (380.0M CNY)
- Status: announced
- Products: diagnostic drugs, contrast agents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GE Healthcare](https://endata.com/companies/4246.md)

## Sources

- [vcbeathealth.com](https://www.vcbeathealth.com/article/15542), 2024-05-21: "On May 15, GE Healthcare announced the signing of a letter of intent for investment cooperation with the Science and Technology and Economy Committee of Pudong New District, Shanghai, to increase investment RMB 380 million RMB."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.